Skip to content
Screener

Xencor XNCR Interest Income

Interest Income at other companies

Janux Therapeutics logo
Janux TherapeuticsJANX
$9.72M-13.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$2.65M-39.9%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$717.17K+377%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$12.15M+68.7%
Regenxbio logo
RegenxbioRGNX
$1.22M-63.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.74M+11.5%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.6B+221%
Enterprise value$1.73B+159%
P/S15.3×+11.9×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses88,28976,780170,667152,695
Operating loss(37,068)(33,172)(114,930)(76,355)
Other income (expense):
Interest income4,8007,24810,25914,786
Interest expense(7,352)(8,243)(12,052)(16,908)
Gains (losses) on equity securities, net18,0644,967(33,865)5,908
Asset impairment charges(797)(1,858)(797)(6,723)
Other, net434(17)830(48)

Item 1. Financial Statements

FAQ

What is Xencor's interest income?
Xencor (XNCR) reported interest income of $4.8M in Q2 2026.
How has Xencor's interest income changed year-over-year?
Xencor's interest income decreased by 33.8% year-over-year, from $7.25M to $4.8M.
What is the long-term trend for Xencor's interest income?
Over 4 years (2021 to 2025), Xencor's interest income has grown at a 137.7% compound annual growth rate (CAGR), from $862K to $27.52M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Xencor's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude